Therapeutics for Age-related Macular Degeneration
Investors 6
| Date | Name | Website |
| 18.08.2021 | Life Scien... | lifescienc... |
| - | Cobro Vent... | cobroventu... |
| - | Band of An... | bandangels... |
| - | Tech Coast... | techcoasta... |
| - | K2X | k2x.capita... |
| - | NuFund Ven... | nufund.com |
Mentions in press and media 6
| Date | Title | Description |
| 17.10.2024 | Visgenx to Present at Eyecelerator @ the American Academy of Ophthalmology Annual Meeting 2024 | Visgenx, a retinal gene therapy Company Presentation will discuss the Company’s gene therapy (VGX-0111) with a novel target for Dry Age-related Macular Degeneration (AMD) We appreciate the opportunity to present at this exciting conference ... |
| 09.05.2024 | Visgenx Announces Presentation of Data Supporting Potential of its Synthetic AAV DNA Platform for Gene Editing at ASGCT | Visgenx, a retinal gene therapy Company Data demonstrate Synthetic AAV genome platform offers promising gene editing alternative to CRISPR based methods due to enhanced safety profile and precision We believe this data provides a promising ... |
| 03.05.2024 | Visgenx to Present at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting | Visgenx, a retinal gene therapy Company Presentation will cover VGX-0111’s ability to raise long chain and very long chain polyunsaturated fatty acids critical to retinal cell health VGX-0111’s ability to raise retinal levels of long chain ... |
| 29.04.2024 | Visgenx to Present at the 9th Annual Retinal Cell and Gene Therapy Innovation Summit | Visgenx, a retinal gene therapy Company Will address the use of Gene Therapy to increase retinal concentrations of Long Chain and Very Long Chain Polyunsaturated Fatty Acids as a treatment for dry AMD The Innovation Summit is sponsored by t... |
| 18.03.2024 | Visgenx to Present at the Second Annual 2024 Cell & Gene Therapy Summit | Visgenx, a retinal gene therapy Company Presentation will discuss the Company’s gene therapy (VGX-0111) with a novel target for Dry AMD) Event is sponsored by Charles River Laboratories I look forward to discussing our lead product VGX-0111... |
| - | Visgenx | “Visgenx” |